SCHEMBL24359262

SCHEMBL24359262

NC(=O)C1CCCN1C(c1ccccc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.45
KDM4E B2RXH2 2/20 0.43
CNR1 P21554 2/20 0.43
CNR2 P34972 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
ALDH1A1 P00352 1/20 0.43
ELANE P08246 2/20 0.42
DPP4 P27487 2/20 0.42
NPSR1 Q6W5P4 3/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
AR P10275 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 2/20 0.41
CYP2D6 P10635 1/20 0.41
POLB P06746 1/20 0.41
OPRD1 P41143 2/20 0.40
OPRM1 P35372 1/20 0.40
OPRK1 P41145 1/20 0.40
OPRL1 P41146 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7305362 1.00 KMT2A (0.45) KMT2AKDM4ECNR1CNR2TDP1
Cadaverine Tartrate SCHEMBL2322053 0.93 KDM4E (0.42) KMT2AKDM4ECNR1CNR2TDP1
SCHEMBL30874883 0.92 KMT2A (0.45) KMT2AKDM4ECNR1CNR2TDP1
SCHEMBL30874890 0.92 KMT2A (0.45) KMT2AKDM4ECNR1CNR2TDP1
SCHEMBL1818486 0.87 ALDH1A1 (0.48) KMT2AKDM4ECNR1CNR2ALDH1A1
SCHEMBL2032193 0.87 ALDH1A1 (0.48) KMT2AKDM4ECNR1CNR2ALDH1A1
SCHEMBL4848261 0.85 KMT2A (0.43) KMT2AKDM4ETDP1ALDH1A1ELANE
SCHEMBL976837 0.85 KMT2A (0.49) KMT2AKDM4ETDP1ELANEDPP4
SCHEMBL7313734 0.85 KMT2A (0.49) KMT2AKDM4ETDP1ELANEDPP4
SCHEMBL19894171 0.81 KMT2A (0.46) KMT2AKDM4ETDP1DPP4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116529252-A Prodrugs for sustained release of therapeutic agents and uses thereof 重庆两江药物研发中心有限公司 2023-08-01 CN disclosed
WO-2022083679-A1 PRODRUGS FOR SUSTAINED RELEASING THERAPEUTIC AGENTS AND USES THEREOF LIANGJIANG MEDICINE CO., LTD. (CN) 2022-04-28 WO disclosed